PExA draws strong interest at ERS lung congress in Barcelona
Bitget2026/09/29 16:41- PExA attended the European Respiratory Society (ERS) congress in Barcelona on Sept. 5-9, drawing strong interest in its lung biomarker technology.
- Management held discussions with healthcare, academic, and pharmaceutical groups from about 20 countries on potential applications in lung disease.
- Three research abstracts using PExA’s non-invasive sampling method were presented at the meeting, covering areas including pulmonary fibrosis and COPD.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BMO lowers Novo Nordisk's target price to $40
Microsoft (MSFT.US) Azure reportedly seeks a 20% cost reduction: intensifying AI costs and talent competition, with simultaneous restructuring of cloud leadership
According to reports, Microsoft (MSFT.US) Azure President Girish Bablani has asked senior leaders in his department to look for ways to reduce costs by at least 20%.

Oil and gas equipment manufacturer VME Companies (VME.US) sets IPO price at $4-$5 per share, plans to raise $18 million
VME Companies, a supplier of offshore oil and gas facility process modules and separation equipment, announced the terms of its IPO on Tuesday.

Wall Street veteran who warned of previous financial crises sounds the bubble alarm: US stock valuations, leverage, and positions are at their most extreme levels in 40 years of industry experience.
David Rosenberg has warned that this is the most tense market in his 40-year career.
